Resolving tumor microenvironment heterogeneity at the single cell level from fixed samples

The tumor microenvironment (TME) has been recognized as a key factor in determining therapeutic responses across various cancer types, yet efforts to explore the full depth and complexity of the TME have been hindered by a lack of adequate tools. Bulk RNA sequencing, flow cytometry, and immunohistochemistry have all led to landmark discoveries in cancer research. However, they have also fallen short due to their lack of resolution, scale, and sample accessibility.

In this webinar, 10x Genomics will present the Single Cell Gene Expression Flex assay, which enables high-throughput RNA sequencing at the single cell level from fixed samples. By introducing simple and ubiquitous fixation conditions, researchers can perform routine whole transcriptome profiling of ~1M single cells across as many as 128 unique samples, while removing supply chain and time constraints from experimental designs. This advanced chemistry allows scientists to investigate the full complexity of the TME and uncover novel insights into cancer biology.

Key learning objectives

  • Discover how single-cell resolution can reveal rare cell populations and the full extent of TME heterogeneity
  • Understand how high-throughput single-cell RNA sequencing (scRNA-seq) can help identify novel biomarkers and inform therapeutic development
  • Learn how the Gene Expression Flex assay expands access with the ability to store and transport samples without losing data quality

Who should attend?

  • Researchers
  • Principal investigators
  • Professors
  • Scientists
  • Post-Doctoral

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Speakers

Luigi Alvarado
Luigi Alvarado
<p>Market Segment Manager, Oncology<br>10x Genomics</p>
Georgina Wynne Hughes
Georgina Wynne Hughes
Editorial Assistant, SelectScience

Links

Tags